ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1997

Adenosine A2A Receptors Maintain Chondrocyte and Cartilage Homeostasis By Maintaining Expression of Anti-Inflammatory Regulators (Nur-77) and Suppressing Expression of Pro-Inflammatory Mediators

Carmen Corciulo1, Cristina Castro2, Samson Jacob3, David Fenyo3 and Bruce N. Cronstein4, 1Department of Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY, 2Medicine, NYU School of Medicine, New York, NY, 3Institute for Systems Genetics, NYU School of Medicine, New York, NY, 4Rheumatology, New York University School of Medicine, Division of Rheumatology, New York, NY

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Adenosine receptors, cartilage, chondrocytes and inflammation

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, October 23, 2018

Title: Osteoarthritis and Joint Biology – Basic Science Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: We have recently reported that adenosine A2A receptor (A2AR) knockout mice develop spontaneous osteoarthritis (OA) and intra-articular injection of adenosine prevents OA progression in a rat model of post-traumatic OA. Changes in chondrocyte gene expression in A2AR KO mice are evident in neonatal mice before OA is apparent. A2AR stimulation has previously been shown to regulate expression of NURR-1, a member of the NR4a family of nuclear receptors. There are 3 members of the NR4a family of nuclear receptors Nurr77, Nurr1 and NOR1 which act as transcriptional regulators to diminish binding of NFkB to its regulatory sites and thereby diminish inflammation. We probed overall expression differences in neonatal chondrocytes from A2AR KO and WT mice and, based on these results, examined the effect of A2AR on NR4a family expression in chondrocytes in vitro and in vivo.

Methods: Knee cartilage from human OA patients, WT and A2ARKO mice, and from OA mice treated with an intrarticular knee injection (10 µl) of empty liposome, liposome containing adenosine or CGS21680 (selective A2AR agonist) were examined immunohistologically for expression of Nurr77, Nurr1 and NOR1. mRNA was isolated from chondrocytes from WT and A2ARKO newborn mice and subject to RNAseq analysis. Human chondrocytic cell line TC28a2 was used to study the effect of A2AR agonists on expression of NR4A receptors.

Results:

RNAseq analysis revealed alteration in expression of 648 genes, of which 319 were downregulated and 329 upregulated in A2ARKO vs WT chondrocytes. Pathway analysis revealed, among other changes, upregulation of pro-inflammatory and downregulation of extracellular matrix pathways in A2ARKO mice. All 3 of the NR4a genes were downregulated (p<0.001) and a number of pro-inflammatory genes were upregulated (e.g. Nfkb1, Rela and MMP-13 (p<0.001)). By immunohistochemistry NOR1, but not NURR77 or NURR1, is highly expressed in knee chondrocytes in healthy human cartilage and NURR1 is upregulated in human OA cartilage. In OA cartilage of A2ARKO mice there is diminished chondrocyte expression of Nur-77 and increased NURR-1 expression. When studied in a murine obesity model of OA intra-articular injection of liposomal suspensions of CGS21680 promoted NURR-1 expression in OA chondrocytes. When studied in vitro in the TC28a2 cell line Nur-77 is present in nuclei and the A2AR agonist stimulated increased nuclear Nur-77, Nurr-1 and Nor-1.

Conclusion: A2AR maintain homeostasis in chondrocytes including maintenance of expression of the anti-inflammatory nuclear receptor Nur-77 in chondrocytes. Diminished Nur-77 expression in OA cartilage likely contributes to OA progression and replacement by Nurr-1 during OA progression is likely insufficient to diminish OA progression but may play a role in A2AR-mediated cartilage repair.


Disclosure: C. Corciulo, Regenosine, 1,Intellectual property, 9; C. Castro, None; S. Jacob, None; D. Fenyo, None; B. N. Cronstein, Cantic Biopharma, Regenosine, 1,NIH Arthitis foundation, Astrazeneca, 2,Horizon Pharmaceuticals, Regenosine, 5,Patent issued and pending, 9.

To cite this abstract in AMA style:

Corciulo C, Castro C, Jacob S, Fenyo D, Cronstein BN. Adenosine A2A Receptors Maintain Chondrocyte and Cartilage Homeostasis By Maintaining Expression of Anti-Inflammatory Regulators (Nur-77) and Suppressing Expression of Pro-Inflammatory Mediators [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/adenosine-a2a-receptors-maintain-chondrocyte-and-cartilage-homeostasis-by-maintaining-expression-of-anti-inflammatory-regulators-nur-77-and-suppressing-expression-of-pro-inflammatory-mediators/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/adenosine-a2a-receptors-maintain-chondrocyte-and-cartilage-homeostasis-by-maintaining-expression-of-anti-inflammatory-regulators-nur-77-and-suppressing-expression-of-pro-inflammatory-mediators/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology